C urrent cancer diagnostics mainly rely on commercialized multistep antibody-based binding assays, such as, ELISA (enzyme-linked immunosorbent assay), 1, 2 Luminex, 3 and Nanosphere 4 for capturing and monitoring target proteins. However, the antibody-based methods require large sample volumes, expensive reagents, or a multistep assay with associated long incubation times. Furthermore, antibody affinity varies from batch to batch, which makes it difficult to develop reliable sensors for clinical molecular diagnostics. In contrast, aptamers, short single-stranded oligonucleotides (RNA or DNA < 100 nt) or peptides (<100-mer) can be produced through a reliable chemical synthesis. 5, 6 Aptamers have high affinity, specificity, and stability; therefore, they are regarded as alternative reagents to antibodies. 7, 8 Furthermore, aptamers change structures from an elongated metastable structure to an uniquely folded stable structure upon interaction with targets. 9À11 Such structural change affords monitoring of targetbinding events without additional labeling steps. Recently, numerous aptamer-based biosensors (aptasensors or aptamer beacons) 12 have exploited the target-binding affinity of aptamers and binding-induced conformational changes in aptamers to monitor the interaction with targets by measuring electron transfer, 13À17 color change, 18À22 or fluorescence quenching. 23À30 However, these methods are limited by either the sensor size or sensitivity or by the associated assay complexity. For example, electrochemical sensors designed to measure an electron transfer require electrodes on a millimeter scale to achieve sufficient sensitivity and colorimetric or fluorescence quenching methods require collecting a large amount of particles to induce a discernible color change or fluorescent signals. A previously reported surfaceenhanced Raman scattering (SERS) aptasensor required multiple binding events: a sandwich assay requiring labeling of target molecules with the complex of gold nanoparticle/ aptamer/Raman probe/silver nanoparticle after capturing the target. 31 Lastly, highly sensitive aptasensors based on surface plasma resonance, 32À34 surface-enhanced resonance Raman scattering (SERRS), 35 and a graphene field-emit transistor (FET) 36 required expensive instruments for measurement, spectral analysis, and sensor fabrication, which limited their extended applications.
In this paper, we present a single-step aptamer-based surface-enhanced fluorescent optical sensor, by combining an aptamerÀtarget interaction for target recognition and a nanoplasmonicÀ fluorophore interaction for signal enhancement.
37À40
The developed aptasensor is simple, sensitive, specific, and stable for the detection of vascular endothelial growth factor-165 (VEGF 165 ), a predominant cancer biomarker in cancer angiogenesis.
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RESULTS AND DISCUSSION
Strong metalÀfluorophore interactions affect the fluorescent intensity significantly. The decay rate of fluorescence increases or decreases depending on the distance from metallic surfaces while the radiative rate in free solution remain relatively constant. The dipole of the fluorophore interacts with free electrons on the metal surface, changing the intensity and temporal and spatial distribution of the radiation. The localization of fluorophores near metal nanoparticles can result in high emission even from "nonfluorescent" molecules and million-fold increases in the number of photons enabling dramatic fluorescent signal enhancement on the nanometer scale.
To implement the metalÀfluorophore interaction, negatively charged, citrate-stabilized gold nanoplasmonic particles (GNPs) are fixed on a positively charged aminosilane coated glass slide. On top of GNPs, positively charged poly-L-lysine (PLL) is applied to attract aptamers and stabilize them via an electrostatic binding interaction. Additionally, the PLL layer serves as a spacing layer to avoid any quenching effects, which may result from a fluorophore in close proximity to metal. To directly monitor a target binding event without requiring an additional labeling step, the VEGF 165 -specific aptamer is conjugated with a fluorescent molecule, Cy3B, which has an absorption peak wavelength (λ = 552 nm) that matches with a localized surface plasmon resonance (LSPR) peak wavelength of a spherical GNP with 80 nm in diameter (λ ≈ 550 nm), 49 expecting an additional signal enhancement.
Aptamer detachment upon target binding is understood by considering a thermodynamic balance between an aptamer folding energy and an electrostatic binding energy to a PLL-coated surface. Gibbs free energy, ΔG (=ΔH À ΔS) is considered to quantify proteins or peptides folding in general thermodynamics. In our case, the detachment of the aptamer provides an example of enthalpy and entropy terms competing with one another to determine if an aptamer folding and detachment is a spontaneous process. As in protein folding, the entropic change of the ARTICLE aptamer and the enthalpic contributions are negative with a heat release upon the folding. Analogous to larger proteins, when all of these entropic and enthalpic contributions are combined, the enthalpy term wins out over the entropy term, the free energy of aptamer folding is negative, and aptamer folding can be a spontaneous process. 50 Therefore, we concentrate on the enthalpy term to calculate the aptamer folding energy and compare with the electrostatic binding energy based on calorimetry in an adiabatic condition.
In the absence of a target molecule, it is designed that an electrostatic binding potential, ΔH E , is of greater magnitude than a spontaneous folding potential, ΔH S : 0 > ΔH S > ΔH E , and the aptamer remains attached to the PLL layer. In this case, Cy3B is spaced at a relevant coupling distance from the GNP surface for the LSPR to induce surface enhanced fluorescence (SEF; Figure 1A ). However, the electrostatic potential can be overcome with an addition target-binding folding potential, ΔH T , which induces a preferable folded structure ( Figure 1B ). In the case that the folding energy is stronger than the electrostatic binding energy, 0 > ΔH E > (ΔH S þ ΔH T ), the aptamer undergoes a conformational change causing the aptamer to contribute less to the immobilization. The loss of the electrostatic energy leads to the subsequent detachment of aptamers from the GNP surface and signal enhancement is precluded ( Figure 1C) . Therefore, the concentration of VEGF 165 molecules can be estimated by measuring the signal change in the fluorescence intensity upon addition of samples.
The spontaneous folding enthalpy of our sequences was calculated to be À66.3 kcal 3 mol À1 (UNAFold, IDT Inc., Coralville, U.S.A.). The electrostatic binding enthalpy was estimated to be À78.2 kcal.mol À1 from an experimental measurement. 51 Based on the experimental results from the reference, the additional transitional enthalpy of their sequences due to a combined PLL of 70 kDa was measured to be À3.4 (=(7.6À14.4)/2) kcal 3 mol À1 3 base pairs À1 on average. Based on the measurement, the binding energy of our 23-base sequences was calculated to be À78.2 kcal 3 mol À1 , and consequently, the binding energy to the target was estimated to be of greater magnitude than À11.9 kcal 3 mol
À1
. Signal enhancement by the metalÀfluorophore interaction was experimentally confirmed by observing the intensity increase of Cy3B by 33% and the radiative decay rate increase by 24% in the presence of GNPs from a fluorescence lifetime spectroscopic measurement (see Supporting Information, Figure S1 ). 52 The simultaneous increase in both the intensity and the decay rate could be only enhanced by the metalÀfluorophore interaction, while an enhanced light mediated by LSPR could enhance only the intensity and a quenching effect could increase the decay rate but decrease intensity. The condition of PLL immobilization was determined at an incubation time of 5 min and with 70 kDa molecular weight of PLL that produced the highest signal sensitivity, the ratio of signal change, ΔI, to control signal in the buffer, I 0 , among the conditions we considered ( Figure 2 ). As for the application to other cancer markers, with given values of the spontaneous and target-binding folding energies, the electrostatic binding energy can be tailored to be from 0 to À6.8 (=7.6À14.4) kcal 3 mol À1 3 base pairs À1 by varying the molecular weight of a linear PLL and the incubation time of aptamer during aptasensor preparation. 53 The kinetics of the aptasensor for VEGF 165 reveals that the signal change reaches saturation within 30 min at 25 ng/mL and about 1 h at 25 pg/mL (Figure 3) . Based on the kinetic study covering the physiological concentration of VEGF 165 in biofluids, all target assays were conducted for an hour. Aptasensors were prepared in an array format fitting to cheaper portable fluorescent scanners for lowcost and simple detection, which was confined by a poly(dimethyl-siloxane) (PDMS) membrane stencil to a silanized glass slide, as shown in Supporting Information, Figure S2 . Measured fluorescent signal changes were normalized by the value of the control.
The sensitivity of the aptasensor was evaluated using serially diluted VEGF 165 solutions in PBS at pH The aptasensor produced a significant signal change with VEGF 165 at 2.5 ng/mL, a peak value of breast cancer samples. 37, 54 For comparison, signal changes from other cancer-related protein concentrations were not significant as follows: platelet-derived growth factor (PDGF)-BB at 2.5 ng/mL 2 and osteopontin (OPN) at 1.5 μg/mL, the peak values of breast cancer samples 55 and noncancer-related common molecules, NaCl at 1 M, an extremely high value, and VEGF 121 at 560 pg/mL, a peak value in healthy donors 44, 54 ( Figure 5 ). However, the correlation with the most abundant nonspecific protein, HSA, at the average value of 40 mg/mL 56 was discernible. Average and standard error were calculated with values from three assays. Our sensing mechanism counts on molecular interactions rather than isoelectric potentials of target molecules. Originally, we were concerned with falsepositive signaling if a negatively charged aptamer would be replaced by other biomolecules mostly having nonzero isoelectric potentials at pH 7.4. Based on the observation of our results, the electrostatic binding energy of the aptamer seemed to be strong enough against the isoelectric potential of proteins we tested and no false-positive signals were detected from other proteins, PDGF-BB, OPN, and VEGF 121 , except HSA.
The false-positive signal with HSA was presumably resulted from the aptamer replacement by negatively charged HSA. HSA has a lower isoelectric point (pI = 5.3) than the 7.4 buffer pH, resulting in a net negative charge contrary to the other proteins examined (VEGF of pI 9.22 and PDGF of pI 9.8), which have a net positive charge in the buffer but weaker than the positive charge of PLL (pK a = 5) to detach the net negatively charged aptamer. The negative potential of HSA may be higher than that of the aptamer and replace our aptamer from the positively charged PLL. If this is the case, the aptamer should be more strongly immobilized by adding extra spacer sequences and increasing the electrostatic binding force in the future.
Also, it was a concern that salt ions at high concentration might induce folding of our aptamer by increasing the rigidity and resulting in any false-negative signaling. 57 To confirm that there was no false signal,
we did an assay with NaCl, the most common salt in The aptasensor for VEGF 165 shows that the signal change increases with time and reaches its saturation value within an hour at a concentration from 25 pg/mL to 25 ng/mL, which covers the physiological ranges of VEGF 165 in clinical samples. Figure 4 . Sensitivity of the aptasensor for VEGF 165 . The aptasensor provides a wide range of detection from 25 pg/mL to 25 μg/mL. The signal changes are linearly proportional to the concentration of VEGF 165 in a log scale. Figure 5 . Specificity of the aptasensor for VEGF 165 . The aptasensor has the high specificity with VEGF 165 against PDGF-BB, OPN (osteopontin), NaCl, and VEGF 121 , but the weak specificity against HSA (human serum albumin). The concentrations of molecules are physiologically relevant values: 2.5 ng/mL (VEGF 165 , PDGF-BB), 1.5 μg/mL (OPN), 560 pg/mL (VEGF 121 ), and 40 mg/mL (HSA), excluding an extreme value of 1 M (NaCl). The cases marked with "*", "**", and "***" correspond to the assays at nominal, peak, and extreme values present in serum or plasma samples.
ARTICLE biofluids, at an extremely high concentration to represent the effects from other ions in biofluids. In our experiment, no discernible signal change was observed.
Our developed aptamer-based sensor is regarded to be superior to or comparable with an antibody-based ELISA detection considering its wide detection range and a low cost for testing. A commercial ELISA kit having the detection range from 5 pg/mL to 2 ng/mL can not cover the physiological level of VEGF 165 in cancer patients (from 500 pg/mL to 8 ng/mL). 44 In the comparative experiments using 100% biofluids of serum and saliva, the detected values of VEGF 165 with aptasensor matched the values with ELISA under 2 ng/ mL, the upper limit of the ELISA kit. Above the limit, the readouts of ELISA was probably saturated and showed lower values than those of aptasensor ( Figure 6 ). The base levels of readouts with aptasensor were elevated in the biofluids probably due to the effect of human serum albumin and the values were calibrated with the obtained sensitivity curve in Figure 4 before the comparison with ELISA. As provided in the Supporting Information, our aptasensor reagents cost only 7.8¢ per test; the multiwell ELISA kit costs $5.36 per test, partially due to the high cost of antibodies. By mass producing aptasensors and decreasing the sensing area, we can drastically reduce the cost of our aptasensor platform to a price-point well below that of ELISA. In our experiment, we used 10 μL of fabrication agents and samples to cover a sensing area of 7 mm 2 , even though an actual detection area was 0.12 mm 2 . If we fabricate sensors in the small area, a required volume can be only 170 pL, and, consequently, required agents can be 60 times less in volume and cost.
Our fully fabricated aptasensor was functional after the storage for more than a month at 4°C (Figure 7 ). Aptasensors were prepared on individual glass slides at the same time and kept at 4°C with an aliminium foil cover to prevent any degradation of Cy3B. Every week, slides were chosen for measuring controls of aptasensors in PBS and for experiments on solutions with 20 μg/mL of VEGF 165 . The aptasensor provided consistent signal changes of 50% within a 5% tolerance, showing the temporal stability of aptamers immobilized on GNP surfaces for a month along with thermal stability up to 95°C provided during sensor preparation and biological stability in biofluids during the assay.
CONCLUSIONS
The single-step aptasensor for VEGF 165 demonstrated target detection with a small amount of sample solutions (less than 10 μL) within an hour at a low cost (less than 10 ¢/test). In addition, the sensor provided a wide range of linear detection from 25 pg/mL to 25 μg/mL, relevant for clinical diagnostics. Also, the aptasensor of VEGF 165 detection showed strong specificity against PDGF-BB, OPN, NaCl, and VEGF 121 , and weak specificity against HSA, which could be improved by SELEX works or aptamer modification. Our aptamer-based sensor showed temporal, thermal, and biological stability relevant for harsh diagnostic environments. Furthermore, the performance of aptasensor was successfully validated in biofluids and compared with conventional ELISA.
EXPERIMENTAL SECTION
Materials and Reagents. RNA oligonucleotides were synthesized by IBA GmbH (Göttingen, Germany), purified via reverse phase HPLC and confirmed by mass spectroscopy to be >85% pure. The RNA oligonucleotides (23- Methods. Preparing Aptasensor. A glass slide was cleaned with Piranha (3:1 concentrated sulfuric acid to 30% hydrogen peroxide solution) for 10 min, thoroughly washed with DI water, and then dried by a nitrogen gun. After the cleaning, the glass slide was coated with amino-terminal groups by immersing in a diluted APS solution (1% v/v in 100% ethanol) for 5 min at room temperature, rinsing with ethanol, and drying it gently with a nitrogen gun without leaving any trace marks. Baking for 5 min at 125°C was applied to further stabilize the amino-group layer. Arrayed holes of 3 mm in diameter were patterned on a thin poly(dimethyl-siloxane) (PDMS) membrane (HT 6240) by using the laser-engraving machine (Versa Laser VL-200, Universal Laser Systems, Scottsdale, AZ, U.S.A.). The patterned PDMS membrane was cleaned with ethanol followed by drying with N 2 gas and in an oven at 60°C for 10 min and then treated with UV/ozone (UVO Cleaner Model 42, Jelight, Irvine, CA) for 3 min to modify the surface of PDMS. GNP stock solution was sonicated (30 s) for even distribution in the stock solution before dropping. A total of 10 μL of the GNP solution was dropped at an opening area defined by the hole on the PDMS membrane and incubated for 1 h at 4°C in a humidity chamber. Unbound GNPs were washed off by rinsing the slide in distilled water and then drying in a centrifuge (IEC clinical centrifuge, International Equipment Co., Needham, MA). A total of 10 μL of PLL (70k Da M.W., 0.1% in distilled water) was dropped at the opening area and incubated for 5 min at room temperature in the humidity chamber. Unbound PLL was washed off by rinsing the slide in distilled water and then drying in a centrifuge. Aptamers at 500 nM were fully dehybridized and stretched by heating to 90°C for 2 min in a dry block heater (HeatBlock I, VWR International, LLC, West Chester, PA) above a calculated melting temperature of 64°C. A 10 μL aliquot of the aptamer solution was dropped immediately at the opening area and incubated for 1 h at 70°C in the humidity chamber. Unbound aptamers were gently washed off by rinsing the slide in PBS by gently pipetting and then drying in a centrifuge.
Target Assay with Aptasensor. For assay, 10 μL samples (biofluids, VEGF 165 , and other molecules) were dropped at the opening area and incubated for 1 h at room temperature in the humidity chamber. Target-combined aptamers and unbound molecules were washed off by gently pipetting each sensor with 10 μL of PBS while avoiding cross-contamination. Thorough washing induced the nonspecific signal loss due to the unwanted detachment of the aptamers and GNPs by a nonspecific mechanical force.
Target Assay with ELISA. Undiluted human serum and saliva samples were assayed for VEGF 165 using an ELISA kit according to the manufacturer's instructions. The concentration of VEGF 165 in these samples was extrapolated from a standard curve generated using a range (0À2 ng/mL) of highly purified Sf 21-expressed recombinant human VEGF 165 .
Biofluid Samples. Nonsmoking participants were recruited at the GCRC, Penn State College of Medicine, Hershey, PA, for this study. All the subjects involved in this study signed the institutional review board-approved consent form. As for the comparative assay, clinical samples were prepard with the mixed population of four healthy women with no known breast disease and four women diagnosed as breast cancer ranging from infiltrating ductal carcinoma, ductal carcinoma in situ, to invasive cribiform carcinoma, and invasive lobular carcinoma. All of the breast cancer patients were recently diagnosed and had not received any prior treatment in the form of chemotherapy, radiotherapy, surgery, or alternative remedies before sample collection. The mean ages for breast cancer patients and healthy donors were 46.0 ( 9.6 yr and 49.3 ( 5.4 yr (P > 0.05, t test), respectively. Fasting blood and stimulated whole saliva samples using base-gum (a gift from Wrigley's) and blood samples were collected. Separated serum and centrifuged saliva samples (12000 rpm for 10 min) were stored at À80°C until used.
Lifetime Measurement. A home-built sample scanning confocal microscope (TE300, Nikon Instruments Inc., Melville, NY) was equipped with a pulsed diode laser (LDH-P-C-470B, PicoQuant GmbH, Berlin, Germany), 470 nm in wavelength, a timecorrelated single photon counting module (PicoHarp 300, Picoquant GmbH, Berlin, Germany), and a piezo scanning stage (Nano-LP 200, Mad City Laboratories Inc., Madison, WI). A fluorescent molecule, Cy3B, conjugated with aptamer was excited by the laser with a power of 2 μW and a pulse rate of 40 MHz. The fluorescence was excited and collected through an oil immersion objective lens (Plan Apochromat, 60Â, N/A = 1.4, Nikon), and filtered with a 580 nm bandpass filter (580DF60, Omega Optical Inc., Brattleboro, VT). The photons were detected with an avalanche photodiode (PDM series, Micro Photon Devices, Bolzano, Italy), and the time delay between the laser pulse and the photons was measured using the PicoHarp 300. From each measurement we acquired images for 10 s, performing a line scan over 100 μm. After the measurement, the lifetimes were fitted by a sum of two exponentials, accounting for a measured instrument response. The sum of the two resulting exponential decay rates, weighted by the amplitudes was used to compute the decay rates changes quoted in Figure S1 .
Fluorescence Imaging. An inverted microscope (TE2000-E, Nikon Instruments Inc., Melville, NY) was coupled with a mercury lamp (1Â HBO 103w/2, OSRAM, München, Germany) and a monochrome CCD camera (Cascade 512B, Photomatrics, Tucson, AZ). The lights were filtered with a TRITC fluorescence filter set (EX: 528À553 nm, DM: 565 nm, BA: 578À633 nm) through an objective lens (Plan Fluor, 20Â, N/A = 0.45, Nikon). The fluorescent images of aptasensors were acquired using a commercial program (Image-pro Express, Media Cybernetics, Inc., Bethesda, MD) with an acquisition time of 200 ms and a gain factor of 3 and then stored in a 16-bit depth monochrome image.
Dark Field Imaging. An inverted microscope (Axiovert 200, Carl Zeiss, Göttingen, Germany) was equipped with a white light illumination (Xenon Light Source 610, KARL STORZ GmbH and Co. KG, Tuttlingen, Germany), a wet dark-field condenser (1.2 < NA < 1.4), and a true-color digital camera (MP3.3-RTV-CLR-10, QImaging, Surrey, BC, Canada). Space between arrayed aptasensors and the condenser was filled with PBS and maintained at room temperature in a complete dark room. The true-color images of aptasensors were taken through an objective lens (LD ACHROPLAN, 40Â, NA = 0.6, Zeiss), acquired with a commercial program (QCapture Pro, Media Cybernetics, Inc., Bethesda, MD) with an acquisition time of 100 ms and a gain factor of 1, and then stored in a 24-bit true color image.
Conflict of Interest: The authors declare no competing financial interest. 
